Search information
Vast Renewables Limited
Companies
"Incentive"
Keywords
Tables in SEC filings
Source
Note | June 30, 2024 | June 30, 2023 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
(In thousands of US Dollars) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
Assets | Current assets: | Cash and cash equivalents | $ | 11,081 | $ | 2,060 | Trade and other receivables | 9 | 839 | 314 | R&D tax incentive receivable | — | 638 | Prepaid expenses | 8 | 1,887 | 44 | Total current assets | 13,807 | 3,056 | Non-current assets: | ||||||||||||||||||||||||||||||||||
Investment in joint venture accounted for using the equity method | 14 | 1,065 | 1,300 | Loans and advances to related parties | 456 | 225 | Property, plant and equipment | 62 | 30 | Right-of-use-assets | 379 | 45 | Total non-current assets | 1,963 | 1,600 | Total assets | $ | 15,770 | $ | 4,656 | Liabilities | ||||||||||||||||||||||||||||||||||
Current liabilities: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
Borrowings and other financial liabilities | 13 | $ | — | $ | 19,812 | Derivative financial instruments | 22 | — | 18 | Trade and other payables | 11 | 5,157 | 5,622 | Contract liabilities | — | 2 | Lease liabilities | 134 | 26 | Warrants liability | 12 | 3,670 | — | Deferred consideration payable | 14 | 959 | 955 | Provisions | 314 | 183 | Total current liabilities | 10,235 | 26,618 | Non-current liabilities: | |||||||||||||||||||||
Lease liabilities | 299 | 28 | Borrowings and other financial liabilities | 13 | 12,821 | 7,134 | Provisions | 156 | 117 | Derivative financial instruments | 22 | 561 | 174 | Total non-current liabilities | 13,836 | 7,453 | Total liabilities | $ | 24,071 | $ | 34,071 | Equity: | |||||||||||||||||||||||||||||||||
Issued capital | 19 | $ | 297,618 | $ | 2,354 | Share-based payment reserve | 20 | 24,294 | 4 | Foreign currency translation reserve | 20 | 2,883 | 3,285 | Capital contribution reserve | 20 | — | 4,591 | Accumulated losses | 21 | (333,094) | (39,649) | Total deficit | $ | (8,300) | $ | (29,415) | Total liabilities and equity | $ | 15,770 | $ | 4,656 |
Year Ended June 30, | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
2024 | 2023 | 2022 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(In thousands of US Dollars) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Cash from operating activities: | Net loss | $ | (293,445) | $ | (15,217) | $ | (6,193) | Adjustments to net loss: | Share in loss of jointly controlled entities | 206 | 254 | 10 | Shares based listing expenses | 106,055 | — | — | Share based payment expense | 1,694 | — | — | Depreciation and amortization expense | 84 | 49 | 47 | Non-cash finance costs recognised in profit or loss | 2,046 | 2,518 | 2,118 | Unrealised (gain)/loss on derivative financial instruments | 164,935 | (105) | 3 | Deferred income tax expense/(benefit) | — | (378) | (618) | Changes in operating assets and liabilities: | Decrease/(Increase) in trade and other receivable | (525) | (233) | 68 | (Increase)/decrease in prepayments | (1,843) | (13) | (28) | (Increase)/decrease in tax incentive receivable | 638 | 76 | 35 | Increase/(decrease) in trade and other payables | (19,126) | 4,079 | 1,149 | Deferred income | — | — | (1,037) | Increase/(decrease) in contract liabilities | 2 | (102) | 104 | Increase in provisions | 170 | 66 | 17 | Foreign exchange differences | (1,200) | (45) | 215 | Net cash (used) in operating activities | $ | (40,309) | $ | (9,051) | $ | (4,110) | Cash flows from investing activities: | Acquisition of interest in joint venture | — | — | (67) | Interest received | 98 | 9 | 1 | Loans and advances paid to related parties | (227) | (144) | (43) | Purchases of property, plant and equipment | (115) | (33) | (15) | Net cash used in investing activities | $ | (244) | $ | (168) | $ | (124) | Cash flows from financing activities: | Payment of deferred consideration | — | (607) | — | Proceeds from borrowings and other financial liabilities | 40,285 | 11,515 | 1,838 | Proceeds from Capital Reorganisation | 9,203 | — | — | Increase/(decrease) in lease liabilities | 45 | (37) | (45) | Net cash generated by financing activities | $ | 49,533 | $ | 10,871 | $ | 1,793 | Net increase/(decrease) in cash and cash equivalents | 8,979 | 1,652 | (2,441) | Effect of exchange rate changes on cash | 42 | (15) | (234) | Cash and cash equivalents at the beginning of the year | 2,060 | 423 | 3,098 | Cash and cash equivalents at the end of the year | $ | 11,081 | $ | 2,060 | $ | 423 |
Year Ended June 30, | |||||||||||||||||||||||||
2024 | 2023 | ||||||||||||||||||||||||
(In thousands of US Dollars) | |||||||||||||||||||||||||
Current tax assets | R&D tax incentive receivable | $ | — | $ | 638 | — | 638 | Deferred tax assets | 1,675 | 419 | Deferred tax liabilities | (1,675) | (419) | Net deferred tax (liability)/asset | $ | — | $ | — |